495
Views
43
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy

, , , , , , , , & show all
Pages 1306-1311 | Received 07 Jan 2007, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David H. Kerman & Amar R. Deshpande. (2014) Gut Microbiota and Inflammatory Bowel Disease: The Role of Antibiotics in Disease Management. Postgraduate Medicine 126:4, pages 7-19.
Read now
Mary Ellen Sanders, Louis M.A. Akkermans, Dirk Haller, Cathy Hammerman, James T. Heimbach, Gabriele Hörmannsperger & Geert Huys. (2010) Safety assessment of probiotics for human use. Gut Microbes 1:3, pages 164-185.
Read now

Articles from other publishers (41)

Yueying Ma, Dandan Yang, Jin Huang, Kunli Liu, Huirong Liu, Huangan Wu & Chunhui Bao. (2024) Probiotics for inflammatory bowel disease: Is there sufficient evidence?. Open Life Sciences 19:1.
Crossref
Ryuichi SAITO, Naoki SATO, Yoichi OKINO, Dian-Sheng WANG & Genichiro SEO. (2023) <i>Bacillus subtilis</i> TO-A extends the lifespan of <i>Caenorhabditis elegans</i>. Bioscience of Microbiota, Food and Health 42:2, pages 124-130.
Crossref
Lingfeng Li, Tianyu Liu, Yu Gu, Xinyu Wang, Runxiang Xie, Yue Sun, Bangmao Wang & Hailong Cao. (2022) Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease. Frontiers in Immunology 13.
Crossref
Jana Štofilová, Monika Kvaková, Anna Kamlárová, Emília Hijová, Izabela Bertková & Zuzana Guľašová. (2022) Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. Biomedicines 10:9, pages 2236.
Crossref
Wenzhen Yuan, Xingpeng Xiao, Xuan Yu, Fuquan Xie, Pengya Feng, Kamran Malik, Jingyuan Wu, Ze Ye, Peng Zhang & Xiangkai Li. (2021) Probiotic Therapy (BIO-THREE) Mitigates Intestinal Microbial Imbalance and Intestinal Damage Caused by Oxaliplatin. Probiotics and Antimicrobial Proteins 14:1, pages 60-71.
Crossref
Kuljit Singh, Tejinder Kaur & Alka Rao. 2022. Biomedical Product and Materials Evaluation. Biomedical Product and Materials Evaluation 635 665 .
Asim K. Duttaroy. 2021. Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease. Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease 311 333 .
Parvirti Dhillon & Kuljit Singh. (2020) Therapeutic applications of probiotics in ulcerative colitis: An updated review. PharmaNutrition 13, pages 100194.
Crossref
Srijita Sireswar, Ishita Ghosh & Gargi Dey. (2019) First and second generation probiotic therapeutics for Inflammatory Bowel Disease. PharmaNutrition 9, pages 100159.
Crossref
Xiang Meng, Hao-Yue Zhou, Hui-Hui Shen, Eniya Lufumpa, Xiao-Mei Li, Biao Guo & Bao-Zhu Li. (2019) Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity. Autoimmunity Reviews 18:5, pages 455-475.
Crossref
Pablo Alagón Fernández del Campo, Alejandro De Orta Pando, Juan Ignacio Straface, José Ricardo López Vega, Diego Toledo Plata, Sebastian Felipe Niezen Lugo, Diego Alvarez Hernández, Tomás Barrientos Fortes, Laila Gutiérrez–Kobeh, Sandra Georgina Solano-Gálvez & Rosalino Vázquez-López. (2019) The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Medical Sciences 7:2, pages 33.
Crossref
Erola Astó, Iago Méndez, Sergi Audivert, Andreu Farran-Codina & Jordi Espadaler. (2019) The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients 11:2, pages 293.
Crossref
Marcos Natal Rufino, Gabriel Francisco Pereira Aleixo, Ingrid Eloise Trombine-Batista, Rogério Giuffrida, Rogéria Keller & Hermann Bremer-Neto. (2018) Systematic review and meta-analysis of preclinical trials demonstrate robust beneficial effects of prebiotics in induced inflammatory bowel disease. The Journal of Nutritional Biochemistry 62, pages 1-8.
Crossref
G. Zoumpopoulou, E. Tsakalidou & L.V. Thomas. 2017. Probiotic Dairy Products. Probiotic Dairy Products 293 357 .
Alyssa Parian. 2017. Integrating Nutrition Into Practice. Integrating Nutrition Into Practice 347 374 .
Lauren E. Hudson, Sarah E. Anderson, Anita H. Corbett & Tracey J. Lamb. (2017) Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clinical Microbiology Reviews 30:1, pages 191-231.
Crossref
R. Chibbar, A. Alahmadi & L.A. Dieleman. 2017. The Microbiota in Gastrointestinal Pathophysiology. The Microbiota in Gastrointestinal Pathophysiology 343 354 .
Lauranne A.A.P. Derikx, Levinus A. Dieleman & Frank Hoentjen. (2016) Probiotics and prebiotics in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 30:1, pages 55-71.
Crossref
Hai-Mei Zhao, Yan Wang, Xiao-Ying Huang, Min-Fang Huang, Rong Xu, Hai-Yang Yue, Bu-Gao Zhou, Hong-Yan Huang, Qi-Meng Sun & Duan-Yong Liu. (2016) Astragalus polysaccharide attenuates rat experimental colitis by inducing regulatory T cells in intestinal Peyer’s patches . World Journal of Gastroenterology 22:11, pages 3175.
Crossref
Danielle Barnes & Ann Ming Yeh. (2015) Bugs and Guts. Nutrition in Clinical Practice 30:6, pages 747-759.
Crossref
Richa Chibbar & Levinus A. Dieleman. (2015) Probiotics in the Management of Ulcerative Colitis. Journal of Clinical Gastroenterology 49:Supplement 1, pages S50-S55.
Crossref
Alyssa ParianMDMD. 2015. Integrative Nutrition Therapy. Integrative Nutrition Therapy 347 374 .
Alyssa M. Parian, Berkeley N. Limketkai, Neha D. Shah & Gerard E. Mullin. (2015) Nutraceutical Supplements for Inflammatory Bowel Disease. Nutrition in Clinical Practice 30:4, pages 551-558.
Crossref
Yasushi Yoshimatsu, Akihiro Yamada, Ryuichi Furukawa, Koji Sono, Aisaku Osamura, Kentaro Nakamura, Hiroshi Aoki, Yukiko Tsuda, Nobuo Hosoe, Nobuo Takada & Yasuo Suzuki. (2015) Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World Journal of Gastroenterology 21:19, pages 5985-5994.
Crossref
Giovanni Cammarota, Gianluca Ianiro, Rossella Cianci, Stefano Bibbò, Antonio Gasbarrini & Diego Currò. (2015) The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacology & Therapeutics 149, pages 191-212.
Crossref
Katsuyuki Fukuda & Yoshiyuki Fujita. (2014) Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis. BMC Gastroenterology 14:1.
Crossref
Rok Orel. (2014) Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World Journal of Gastroenterology 20:33, pages 11505.
Crossref
Frank I. Scott & Faten N. Aberra. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 209 220 .
Páraic Ó Cuív, Eline S. Klaassens, Wendy J. Smith, Stanislas Mondot, A. Scott Durkin, Derek M. Harkins, Les Foster, Jamison McCorrison, Manolito Torralba, Karen E. Nelson & Mark Morrison. (2013) Draft Genome Sequence of Enterococcus faecalis PC1.1, a Candidate Probiotic Strain Isolated from Human Feces. Genome Announcements 1:1.
Crossref
Richard Fedorak & Denny Demeria. (2012) Probiotic Bacteria in the Prevention and the Treatment of Inflammatory Bowel Disease. Gastroenterology Clinics of North America 41:4, pages 821-842.
Crossref
Daisy Jonkers, John Penders, Ad Masclee & Marieke Pierik. (2012) Probiotics in the Management of Inflammatory Bowel Disease. Drugs 72:6, pages 803-823.
Crossref
Khimara Naidoo, Morris Gordon, Andrew O Fagbemi, Adrian G Thomas & Anthony K Akobeng. (2011) Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews.
Crossref
Asa Hakansson & Goran Molin. (2011) Gut Microbiota and Inflammation. Nutrients 3:6, pages 637-682.
Crossref
Richard N. Fedorak, Levinus A. Dieleman & Karen L. Madsen. 2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease 123 150 .
Harald Matthes, Thomas Krummenerl, Manfred Giensch, Corinna Wolff & Jürgen Schulze. (2010) Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complementary and Alternative Medicine 10:1.
Crossref
Leo R. Fitzpatrick & Kelly Dowhower Karpa. 2010. Bioactive Foods in Promoting Health. Bioactive Foods in Promoting Health 571 587 .
Luca Prisciandaro, Mark Geier, Ross Butler, Adrian Cummins & Gordon Howarth. (2009) Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflammatory Bowel Diseases 15:12, pages 1906-1914.
Crossref
M Geier, L Prisciandaro & G Howarth. 2009. Handbook of Prebiotics and Probiotics Ingredients. Handbook of Prebiotics and Probiotics Ingredients.
Ajay S. Gulati & Marla C. Dubinsky. (2009) Probiotics in pediatric inflammatory bowel diseases. Current Gastroenterology Reports 11:3, pages 238-247.
Crossref
San Choon Kong. (2009) Probiotics and prebiotics in the management of ulcerative colitis. Food Science & Technology Bulletin: Functional Foods 5:8, pages 93-102.
Crossref
Gordon S Howarth. (2008) Inflammatory bowel disease, a dysregulated host‐microbiota interaction: Are probiotics a new therapeutic option?. Journal of Gastroenterology and Hepatology 23:12, pages 1777-1779.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.